newsfilter
← Latest News
GlobeNewswire·

Tempest Appoints John W. Frederick to Board of Directors, Strengthening Financial and Capital Markets Expertise

BRISBANE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing in vivo CAR-T therapies designed to reset